Agostoni P, Cattadori G, Guazzi M, Bussotti M, Conca C, Lomanto M, Marenzi G, Guazzi M D
Centro Cardiologico, Fondazione Monzino IRCCS, Istituto di Cardiologia dell' Università di Milano, Centro di Studio per le Ricerche Cardiovascolari del CNR, Milan, Italy.
Am J Med. 2000 Oct 15;109(6):450-5. doi: 10.1016/s0002-9343(00)00532-5.
Patients with stable heart failure often wish to spend time at altitudes above those of their residence. However, it is not known whether they can safely tolerate ascent to high altitudes or what its effects on work capacity may be.
We studied 14 normal subjects and 38 patients with clinically stable heart failure, 12 of whom had normal workload [peak exercise oxygen consumption (VO(2)) greater than 20 mL/min/kg], 14 of whom had slightly diminished workload (peak VO(2) 20 to 15 mL/min/kg), and 12 of whom had markedly diminished workload (peak VO(2) less than 15 mL/min/kg) at baseline. All performed cardiopulmonary exercise tests with inspired oxygen fractions equal to those at 92, 1,000, 1,500, 2,000, and 3,000 m, and maximum achieved work rates (mean +/- SD) were measured.
All subjects completed the trial; no test was interrupted because of arrhythmia, angina, or ischemia. Maximum work rate decreased in parallel with increasing simulated altitude. The percentage decrease was greater for patients with heart failure and was most marked among those with the lowest workload at baseline. Maximum achieved work rate declined by 3% +/- 4% per 1,000 m in normal subjects, by 5% +/- 3% (P <0.01) in patients with heart failure with normal workload, by 5% +/- 4% (P <0.01) in patients with slightly diminished workload, and by 11% +/- 5% (P <0.01 vs normal subjects and vs the other patients with heart failure) in patients with markedly reduced workload.
Patients with stable heart failure who ascend to higher altitudes should expect to have a reduction in maximum physical activity in proportion to their exercise capacity at sea level.
稳定性心力衰竭患者常希望前往海拔高于其居住地的地方。然而,尚不清楚他们能否安全耐受海拔升高,以及这对工作能力会有何影响。
我们研究了14名正常受试者和38名临床稳定性心力衰竭患者,其中12名患者基线时工作负荷正常[峰值运动耗氧量(VO₂)大于20 mL/min/kg],14名患者工作负荷略有降低(峰值VO₂为20至15 mL/min/kg),12名患者工作负荷明显降低(峰值VO₂小于15 mL/min/kg)。所有受试者均进行了心肺运动试验,吸入氧分数与海拔92米、1000米、1500米、2000米和3000米处相同,并测量了最大运动负荷(平均值±标准差)。
所有受试者均完成试验;无试验因心律失常、心绞痛或缺血而中断。最大运动负荷随模拟海拔升高而平行下降。心力衰竭患者的下降百分比更大,且在基线时工作负荷最低的患者中最为明显。正常受试者每升高1000米,最大运动负荷下降3%±4%;工作负荷正常的心力衰竭患者下降5%±3%(P<0.01),工作负荷略有降低的患者下降5%±4%(P<0.01),工作负荷明显降低的患者下降11%±5%(与正常受试者及其他心力衰竭患者相比,P<0.01)。
前往更高海拔的稳定性心力衰竭患者应预期其最大体力活动会根据其海平面运动能力按比例下降。